OTCMKTS:BIEI

Premier Biomedical - BIEI Stock Forecast, Price & News

$0.0014

0.00 (0.00%)

(As of 10/3/2022 12:00 AM ET)

Add

Compare

Today's Range: $0.0013
▼
$0.0016
50-Day Range: N/A
52-Week Range: $0.0012
▼
$0.0072

Volume: 454,144 shs
Average Volume: 4.55 million shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Premier Biomedical (OTCMKTS:BIEI) Stock

Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil capsule, and pet product; sequential-dialysis technique for cancer, Alzheimer's disease, ALS, blood sepsis, leukemia, and other life-threatening cancers; and Feldetrex drug candidate for the treatment of multiple sclerosis, fibromyalgia, neuropathic pain, and traumatic brain injuries. Premier Biomedical, Inc. was founded in 2010 and is headquartered in Jackson Center, Pennsylvania.

Receive BIEI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Premier Biomedical and its competitors with MarketBeat's FREE daily newsletter.

BIEI Stock News Headlines

August 12, 2022 | apnews.com

BIOMEDevice Boston Brings Back “Master Class Start-Up Series” in Partnership with MassMEDIC

August 8, 2022 | ca.finance.yahoo.com

Premier Biomedical, Inc. (BIEI)

May 17, 2022 | apnews.com

BioIVT to Provide Rare Biosamples for the FNIH Biomarkers Consortium Neurodegenerative Disease Project

October 26, 2021 | finance.yahoo.com

Premier Biomedical Appoints Dr. Patricio Reyes to Board and Chief Technical Officer

November 15, 2020 | nasdaq.com

BIEI After-Hours Quotes

August 9, 2020 | barrons.com

Premier Biomedical Inc.

June 17, 2020 | www.bloomberg.com

Premier Biomedical Inc., CEO William Hartman Visits Uptick Newswire’s “Stock Day” with Everett Jolly

June 5, 2020 | www.finanznachrichten.de

Halberd Corporation: Halberd Corp. Announces Correction/Clarification to Eliminate Name Confusion

June 5, 2020 | finance.yahoo.com

Halberd Corp. Announces Correction/Clarification to Eliminate Name Confusion

May 12, 2020 | finance.yahoo.com

Premier Biomedical, Technology Health, and Datatecnics Agree to Collaborate on Extracorporeal "Map and Zap(TM)" Coronavirus Treatment

May 5, 2020 | www.finanznachrichten.de

Premier Biomedical, Inc.: Premier Biomedical Rescinds Previously Planned Increase in Authorized Shares

May 5, 2020 | finance.yahoo.com

Premier Biomedical Rescinds Previously Planned Increase in Authorized Shares

April 14, 2020 | finance.yahoo.com

Premier Biomedical, Inc. Announces Second Covid-19 Treatment Provisional Patent Application Filed to Supplement Two Issued Patents

April 8, 2020 | finance.yahoo.com

Premier Biomedical, Halberd and Gold River Agree to Work Jointly to Develop Premier's Patented Extracorporeal Technology on COVID-19 Treatment And Proprietary Anti-Addiction Patch(TM)

April 6, 2020 | finance.yahoo.com

Premier Biomedical Realigns Business to Eliminate Convertible Debt, Cancel Reverse Split & Fund Covid-19 R&D

March 23, 2020 | finance.yahoo.com

Covid-19 Treatment Provisional Patent Application Filed; Premier Biomedical, Inc. Granted Global Commercial Rights

November 14, 2019 | www.finanznachrichten.de

Premier Biomedical, Inc.: Premier Biomedical Announces Evolution of Business Focus and Name Change

November 14, 2019 | finance.yahoo.com

Premier Biomedical Announces Evolution of Business Focus and Name Change

November 1, 2019 | markets.ft.com

Premier Biomedical Inc

October 21, 2019 | finance.yahoo.com

Premier Biomedical, Inc. CEO, William Hartman, Addresses Current Challenges with The Stock Day Podcast

September 19, 2019 | www.finanznachrichten.de

Premier Biomedical, Inc. Joins The Stock Day Podcast to Announce The Release of Its Anti-Addiction Patch

September 19, 2019 | finance.yahoo.com

Premier Biomedical, Inc. Joins The Stock Day Podcast to Announce The Release of Its Anti-Addiction Patch(TM)

August 12, 2019 | finance.yahoo.com

CEO, William Hartman, Joins The Stock Day Podcast to Discuss Their New Joint Venture and Upcoming Anti-Addiction Patch

July 30, 2019 | finance.yahoo.com

Premier Biomedical Signs Joint Venture Agreement With New Earth Development, RushNet Inc., and XYZ Hemp, Inc. to Market New Anti-Addiction Patch

February 20, 2019 | finance.yahoo.com

Uptick Newswire Hosts Premier Biomedical, Inc. on The Stock Day Podcast to Discuss the Company’s Current Projects

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive BIEI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Premier Biomedical and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Drug Manufacturers - Specialty & Generic
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:BIEI
CUSIP: N/A
CIK: 1515740
Web: www.premierbiomedical.com
Phone: 724 633 7033
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Key Executives

Mr. David Caplan
Pres, Chairman of Directors, Sec. & Treasurer

Mr. Carl Eller
Marketing & Planning Vice-Pres

Key Competitors

View All Competitors

BIEI Stock - Frequently Asked Questions

How have BIEI shares performed in 2022?: Premier Biomedical's stock was trading at $0.0034 at the beginning of 2022. Since then, BIEI shares have decreased by 55.9% and is now trading at $0.0015.
View the best growth stocks for 2022 here.
What other stocks do shareholders of Premier Biomedical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Premier Biomedical investors own include Co-Diagnostics (CODX), Allena Pharmaceuticals (ALNA), CytoDyn (CYDY), Inovio Pharmaceuticals (INO), Sierra Oncology (SRRA), Vaxart (VXRT), MEI Pharma (MEIP), Novavax (NVAX), Rigel Pharmaceuticals (RIGL) and Selecta Biosciences (SELB).

What is Premier Biomedical's stock symbol?: Premier Biomedical trades on the OTCMKTS under the ticker symbol "BIEI."
How do I buy shares of Premier Biomedical?: Shares of BIEI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Premier Biomedical's stock price today?: One share of BIEI stock can currently be purchased for approximately $0.00.
How can I contact Premier Biomedical?: Premier Biomedical's mailing address is PO Box 31374, EL PASO, TX 79931-0374, United States. The official website for the company is www.premierbiomedical.com. The company can be reached via phone at 724 633 7033.

This page (OTCMKTS:BIEI) was last updated on 10/3/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms